CD274 and cancer: In combination, these findings point to a previously unappreciated role AR has on PD-L1 expression in multiple tissue types and, given that the PD-1/PD-L1 axis is an actionable immunotherapeutic target for various cancers, indicate that AR activity can impact the response to immunotherapy.